Author:
Wang Yilong,Zhang Yun,Hu Yunfeng
Funder
National Natural Science Foundation of China
Strategic Priority Research Program of the Chinese Academy of Sciences
Guangzhou Science and Technology Plan Projects
project “Engineering High-Performance Microorganisms for Advanced Bio-Based Manufacturing” from the Chinese Academy of Sciences
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference32 articles.
1. Patel, R. N. (2008). Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coordination Chemistry Reviews, 252, 659–701.
2. Tseng, H.-C., Martin, C. H., Nielsen, D. R., & Prather, K. L. J. (2009). Metabolic engineering of Escherichia coli for enhanced production of (R)- and (S)-3-hydroxybutyrate. Applied and Environmental Microbiology, 75, 3137–3145.
3. Patel, R. N. (2002). Microbial/enzymatic synthesis of chiral intermediates for pharmaceuticals. Enzyme and Microbial Technology, 31, 804–826.
4. Pollard, D. J., & Woodley, J. M. (2007). Biocatalysis for pharmaceutical intermediates: the future is now. Trends in Biotechnology, 25, 66–73.
5. Patel, R. N. (2006). Biocatalysis: synthesis of chiral intermediates for drugs. Current Opinion in Drug Discovery & Development, 9, 741–764.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献